{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-024449","form_type":"8-K","ticker":"PVCT","cik":"0000315545","company_name":"PROVECTUS BIOPHARMACEUTICALS, INC.","filed_at":"2024-06-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.528282+00:00","generated_at":"2026-06-01T03:44:48.375172+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.12,"calibrated_materiality_score":0.12,"confidence":"low","headline":"Provectus presents annual meeting update covering R&D and corporate activities; no specific results disclosed","bullets":["Update covers clinical development, regulatory, drug discovery, manufacturing, IP, and business development.","No financial or clinical data points released in the filing.","Presentation slides furnished as Exhibit 99.1 but not reproduced in the text."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-024449","json":"https://secwatch.observer/filing/0001493152-24-024449.json","markdown":"https://secwatch.observer/filing/0001493152-24-024449.md","text":"https://secwatch.observer/filing/0001493152-24-024449.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/315545/000149315224024449/0001493152-24-024449-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/315545/000149315224024449/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T03:44:48.375172+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}